Ireland
--:--IST
Latest
Clinical Trials in France / NCT06182956
Starting soon Not applicable

NIV Versus HFO for Acute Exacerbations of Interstitial Lung Diseases

NCT06182956 · tracked via the Priya Life Science France tracker
Phase
Not applicable
Started
2024-01-01
Last updated
2023-12-27

Condition(s) studied

Interstitial Lung DiseaseAcute Respiratory Failure

Investigational drug(s) / intervention(s)

Noninvasive mechanical ventilationNasal high-flow oxygen therapyContinuous positive airway pressure

Noninvasive mechanical ventilation: Noninvasive mechanical ventilation is a respiratory technique which allows the administration of positive inspiratory and expiratory airway pressures in order to ventilate the lungs.

Nasal high-flow oxygen therapy: Nasal high-flow is a respiratory technique which allows the administration of warmed and humidified air, associated with oxygen.

Continuous positive airway pressure: Continuous positive airway pressure is a respiratory technique which allows to maintain a constant positive airway pressure during inspiration and expiration.

Study summary

The objectives of this study are to compare the physiological consequences of high-flow oxygen therapy and noninvasive mechanical ventilation on ventilation, respiratory work and hemodynamics during acute respiratory failure in diffuse interstitial pneumonia.

Eligibility

Sex
ALL
Min age
18 Years
Max age
—
Healthy volunteers
No
Inclusion criteria: * Age \> 18 yrs * Hospitalization in intensive care unit * Acute exacerbation of a previously/presently documented diffuse (fibrotic) interstitial lung disease * Dyspnea majoration since at least 1 month * Alveolar or ground-glass opacities on CT-scan that are superposed to interstitial lung disease and not explained by left heart failure or volume overload * Hypoxemia requiring oxygen flows \> 6 L/min Exclusion criteria: * Contraindication to noninvasive ventilation or high-flow oxygen therapy * Immediate indication to endotracheal intubation or hemodynamic assistance * Body mass index \> 40 * Presence of a pacemaker or an implantable defibrillator * Presence of cutaneous lesions where Pulmovista® belt should be placed * Moribund patient * Pregnant or breastfeeding women or women of childbearing age without an effective method of contraception * Protected adult patient (tutorship or curatorship) * Patient deprived of liberty by court or administrative decision * No possibility to install nasogastric tube * Endotracheal or tracheostomy tube requirement during the study * Hemodynamic assistance requirement during the study

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
ADIR Association Rouen France

More ADIR Association trials in France

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT06182956 on ClinicalTrials.gov ↗ ← All trials in France